KemPharm
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-16.76-0.22-0.16-0.16-0.08-0.03-0.02-1.74-30.30-3.81-4.82-0.03
Price/Sales ratio
N/AN/AN/AN/AN/AN/A0.051.679.0415.1319.16N/A
Price/Book Value ratio
-3.61-0.22-0.90-0.14-0.06-0.02-0.00-0.332.031.842.33-0.06
Price/Cash Flow ratio
-20.24-0.37-0.45-0.09-0.11-0.03-0.02-11.4924.83-8.45-10.70-0.03
Price/Free Cash Flow ratio
-20.01-0.37-0.44-0.08-0.11-0.03-0.02-11.3025.08-8.41-10.65-0.03
Price/Earnings Growth ratio
N/A-0.00-0.000.00-0.00-0.000.000.020.33-0.01-0.14-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A77.06%90.17%92.81%96.72%96.72%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-158.40%-35.97%26.97%-237.54%-68.64%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-191.16%-96.28%-29.74%-404.75%-404.75%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-190.99%-96.02%-29.86%-397.23%-397.23%N/A
Effective Tax Rate
0.38%0.09%-0.04%0.09%0.09%0.22%0.08%0.26%-0.39%1.85%1.85%0.09%
Return on Assets
-215.15%-178.32%-98.09%-19.45%-82.70%-211.11%-233.38%-113.83%-6.43%-35.95%-35.95%-82.70%
Return On Equity
21.53%100.62%540.10%88.33%75.43%84.82%32.93%19.21%-6.72%-48.41%-41.50%84.82%
Return on Capital Employed
167.66%-168.14%-48.15%-47.90%-81.48%-379.20%-400.65%-130.16%6.00%-23.93%-6.91%-81.48%
Liquidity Ratios
Current Ratio
N/AN/A6.4811.194.081.971.221.11N/AN/A7.934.08
Quick Ratio
0.372.616.4811.194.081.971.221.0927.27.877.774.08
Cash ratio
0.372.603.872.520.941.530.590.5526.555.585.580.94
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A53.0270.8419.46289.64289.64N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A30.48N/A714.03N/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A53.02101.3219.461.00K71.41N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A141.29328.3691.473.84K3.84KN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A-88.27-227.03-72.00-2.83K-3.55KN/A
Debt Ratios
Debt Ratio
10.991.320.411.071.773.057.566.270.010.120.253.05
Debt Equity Ratio
-0.16-0.74-2.28-4.88-1.61-1.22-1.06-1.050.010.160.34-1.61
Long-term Debt to Capitalization
-0.00-2.912.061.252.806.7616.5521.590.000.130.176.76
Total Debt to Capitalization
-0.19-2.931.771.252.625.4115.6717.850.010.140.215.41
Interest Coverage Ratio
N/AN/A-8.54-5.25-4.54-7.65-3.12-0.67N/AN/A-16.77-7.65
Cash Flow to Debt Ratio
-1.10-0.80-0.87-0.32-0.35-0.66-0.29-0.026.57-1.32-0.80-0.66
Company Equity Multiplier
-0.10-0.56-5.50-4.54-0.91-0.40-0.14-0.161.041.341.34-0.91
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-1.84-0.140.36-1.78-1.78N/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.001.021.001.001.001.010.991.001.001.00
Cash Flow Coverage Ratio
-1.10-0.80-0.87-0.32-0.35-0.66-0.29-0.026.57-1.32-0.80-0.66
Short Term Coverage Ratio
-1.11-465.74-5.89-189.63-9.39-15.28-83.58-2.7029.32-38.99-3.64-9.39
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A